Oncternal Therapeutics In... (ONCT)
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 9:00 PM
Oncternal Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 |
| Revenue | 785K | 1.49M | 4.32M | 3.38M | 2.42M | 2.52M | 1.67M | -2.51M | n/a | n/a | n/a | n/a | 14.74M | 60.61M | 14.73M | 13.53M | 7.13M | 7.5M | 3.78M | 1.87M | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 29.75M | 179K | 169K | 12M | 10.16M | 46K | 47K | 2.51M | 43K | n/a | n/a | n/a | 1.05M | 768K | 1.29M | 649K | 621K | 773K | 1.57M | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -28.97M | 1.31M | 4.15M | -8.63M | -7.73M | 2.48M | 1.63M | -5.02M | -43K | n/a | n/a | n/a | 13.68M | 59.84M | 13.44M | 12.88M | 6.5M | 6.73M | 2.21M | 1.87M | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -41.71M | -44.95M | -31.37M | -17.54M | -33.11M | -39.06M | -30.66M | -25.93M | -21.84M | -30.35M | -43.6M | -49.73M | -33.69M | 13.93M | -46.65M | -54.48M | -45.5M | -38.52M | -38.56M | -23.29M | -14.34M | -12.02M | -8.15M | -3.96M | -819K |
| Interest Income | 2.23M | 777K | 33K | 16K | 188K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 159K | 2.71M | 5.14M | 3.01M | 1.72M | 946K | 143K | n/a | 83K | n/a | n/a |
| Pretax Income | -39.48M | -44.17M | -31.33M | -17.23M | -34.19M | -38.42M | -30.44M | -17.72M | -18.7M | -39.41M | -42.11M | -49.75M | -33.29M | 15.29M | -46.49M | -51.78M | -40.36M | -35.51M | -36.84M | -5.68M | -95.47M | n/a | n/a | n/a | n/a |
| Net Income | -39.48M | -43.39M | -31.3M | -17.21M | -15.91M | -38.42M | -30.44M | -17.72M | -18.7M | -39.41M | -42.11M | -27.07M | -33.29M | 15.29M | -46.26M | -51.78M | -40.36M | -35.51M | -36.84M | -22.35M | -14.19M | -11.87M | -8.06M | -3.81M | -750K |
| Selling & General & Admin | 12.75M | 13.46M | 11.6M | 8.37M | 7.29M | 9.39M | 9.19M | 8.71M | 8.23M | 9.48M | 11.28M | 10.85M | 15.44M | 17.42M | 27.75M | 23.11M | 13.5M | 11.35M | 9.85M | 7.21M | 3.51M | 2.4M | 2.23M | 1.2M | 256K |
| Research & Development | 29.75M | 32.98M | 24.09M | 12.54M | 10.16M | 29.67M | 21.47M | 17.23M | 13.61M | 20.87M | 32.32M | 38.89M | 31.94M | 28.5M | 32.34M | 44.26M | 38.51M | 33.9M | 30.92M | 17.95M | 10.47M | 9.29M | 5.92M | 2.68M | 518K |
| Other Expenses | -29.75M | -1.49M | -4.32M | -3.38M | -2.42M | 641K | 216K | 46K | 57K | -259K | 1.49M | -19K | 15.44M | n/a | n/a | n/a | 13.5M | 11.35M | 9.85M | 7.21M | 357K | n/a | n/a | n/a | n/a |
| Operating Expenses | 12.75M | 44.95M | 31.37M | 17.54M | 15.02M | 39.06M | 30.66M | 25.93M | 21.84M | 30.35M | 43.6M | 49.73M | 47.38M | 45.91M | 60.09M | 67.36M | 52.01M | 45.25M | 40.77M | 25.16M | 14.34M | 12.02M | 8.15M | 3.96M | 819K |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 42.5M | 44.95M | 31.37M | 17.54M | 15.02M | 39.06M | 30.66M | 25.93M | 21.84M | 30.35M | 43.6M | 49.73M | 48.43M | 46.68M | 61.38M | 68.01M | 52.63M | 46.02M | 42.34M | 25.16M | 14.34M | 12.02M | 8.15M | 3.96M | 819K |
| Income Tax | n/a | -777K | -33K | -16K | -18.28M | 641K | -47K | -8.19M | -3.12M | 8.7M | -384K | -8.82M | -1.44M | -2.94M | -238K | -1.56M | 4.9M | -72.03M | 299K | 17.25M | -143K | -156K | 8.06M | -150K | -69K |
| Shares Outstanding (Basic) | 2.94M | 2.63M | 2.47M | 1.02M | 516.45K | 3.34M | 2.49M | 2.08M | 2.01M | 1.17M | 900.82K | 897.27K | 819.42K | 555.35K | 520.22K | 518.59K | 499.14K | 445K | 371.18K | 328.47K | 110.5K | 110.5K | 110.68K | 110.5K | 110.5K |
| Shares Outstanding (Diluted) | 2.94M | 2.63M | 2.47M | 1.02M | 516.45K | 3.34M | 2.49M | 2.08M | 2.11M | 1.17M | 900.82K | 897.27K | 819.42K | 555.35K | 520.22K | 518.59K | 499.14K | 445K | 371.18K | 343.75K | 110.5K | 110.5K | 110.68K | 110.5K | 110.5K |
| EPS (Basic) | -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -9.33 | -33.72 | -46.75 | -30.17 | -40.63 | 27.30 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -68.04 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
| EPS (Diluted) | -13.43 | -16.5 | -12.69 | -16.95 | -30.81 | -11.52 | -12.22 | -8.52 | -8.86 | -33.72 | -46.75 | -30.17 | -40.63 | 27.30 | -88.92 | -99.85 | -80.86 | -79.8 | -99.25 | -65.01 | -128.45 | -107.39 | -72.85 | -34.5 | -6.79 |
| EBITDA | 2.23M | -44.95M | -31.37M | -17.54M | -33.11M | 1.01M | -30.39M | -17.7M | -18.66M | -39.31M | -41.73M | -49M | -34.09M | 16.87M | -44.71M | -52.92M | -45.5M | -34.37M | -38.56M | -23.29M | n/a | -11.69M | -8.15M | -3.88M | -774K |
| Depreciation & Amortization | 41.71M | 179K | 169K | 150K | 15.02M | 7.59M | 47K | 28K | 43K | 102K | 384K | 750K | 1.04M | 1.57M | 1.78M | 1.56M | -4.9M | -5.01M | -299K | -580K | 357K | 332K | n/a | 80K | 45K |